Hypoxia-Induced Suppression of Antiapoptotic Bcl-2 Expression in Human Bladder Tumor Cells Is Regulated by Caveolin-1-Dependent Adenosine Monophosphate-Activated Protein Kinase Activity
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Adenosine monophosphate-activated protein kinase (AMPK) is thought to inhibit cell proliferation or promote cell death, but the details remain unclear. In this study, we propose that AMPK inhibits the expression of anti-apoptotic B-cell lymphoma 2 (Bcl-2) by relying on the hypoxia-inducible factor 1 alpha (HIF-1α)-induced caveolin-1 (Cav-1) expression pathway in noninvasive human bladder tumor (RT4) cells. Methods: In cells exposed to a hypoxic environment (0.5% oxygen), the levels of expression and phospho-activity of the relevant signaling enzymes were examined via Western blots and reverse transcription-polymerase chain reaction. Cell proliferation was assessed using a Cell Counting Kit-8 assay. Results: The level of expression of Cav-1 was very low or undetectable in RT4 cells. Hypoxia was associated with significantly decreased cell growth, along with marked induction of HIF-1α and Cav-1 expression; additionally, it suppressed the expression of the antiapoptotic marker Bcl-2 while leaving AMPK activity unchanged. Under hypoxic conditions, HIF-1α acts as a transcription factor for Cav-1 mRNA gene expression. The cell growth and Bcl-2 expression suppressed under hypoxia were reversed along with decreases in the induced HIF-1α and Cav-1 levels by AMPK activation with metformin (1mM) or phenformin (0.1mM). In addition, pretreatment with AMPK small interfering RNA not only increased the hypoxia-induced expression of HIF-1α and Cav-1, but also reversed the suppression of Bcl-2 expression. These results suggest that HIF-1α and Cav-1 expression in hypoxic environments is regulated by basal AMPK activity; therefore, the inhibition of Bcl-2 expression cannot be expected when AMPK activity is suppressed, even if Cav-1 expression is elevated. Conclusions: For the first time, we find that AMPK activation can regulate HIF-1α induction as well as HIF-1α-induced Cav- 1 expression, and the hypoxia-induced inhibitory effect on the antiapoptotic pathway in RT4 cells is due to Cav-1-dependent AMPK activity.
Abstract
Purpose: Adenosine monophosphate-activated protein kinase (AMPK) is thought to inhibit cell proliferation or promote cell death, but the details remain unclear. In this study, we propose that AMPK inhibits the expression of anti-apoptotic B-cell lymphoma 2 (Bcl-2) by relying on the hypoxia-inducible factor 1 alpha (HIF-1α)-induced caveolin-1 (Cav-1) expression pathway in noninvasive human bladder tumor (RT4) cells. Methods: In cells exposed to a hypoxic environment (0.5% oxygen), the levels of expression and phospho-activity of the relevant signaling enzymes were examined via Western blots and reverse transcription-polymerase chain reaction. Cell proliferation was assessed using a Cell Counting Kit-8 assay. Results: The level of expression of Cav-1 was very low or undetectable in RT4 cells. Hypoxia was associated with significantly decreased cell growth, along with marked induction of HIF-1α and Cav-1 expression; additionally, it suppressed the expression of the antiapoptotic marker Bcl-2 while leaving AMPK activity unchanged. Under hypoxic conditions, HIF-1α acts as a transcription factor for Cav-1 mRNA gene expression. The cell growth and Bcl-2 expression suppressed under hypoxia were reversed along with decreases in the induced HIF-1α and Cav-1 levels by AMPK activation with metformin (1mM) or phenformin (0.1mM). In addition, pretreatment with AMPK small interfering RNA not only increased the hypoxia-induced expression of HIF-1α and Cav-1, but also reversed the suppression of Bcl-2 expression. These results suggest that HIF-1α and Cav-1 expression in hypoxic environments is regulated by basal AMPK activity; therefore, the inhibition of Bcl-2 expression cannot be expected when AMPK activity is suppressed, even if Cav-1 expression is elevated. Conclusions: For the first time, we find that AMPK activation can regulate HIF-1α induction as well as HIF-1α-induced Cav- 1 expression, and the hypoxia-induced inhibitory effect on the antiapoptotic pathway in RT4 cells is due to Cav-1-dependent AMPK activity.
참고문헌 (35)
- Rajjayabun PH, "Caveolin-1 expression is associated with high-grade bladder cancer", Urology, 58, pp.811~814 (2001)
- Fong A, "Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation", Am J Clin Pathol, 120, pp.93~100 (2003)
- Thomas S, "Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer", Cancer Res, 71, pp.832~841 (2011)
- Liang W, "CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition", Urol Oncol, 32, pp.855~863 (2014)
- Gleadle JM, "Hypoxia and the regulation of gene expression", Mol Med Today, 4, pp.122~129 (1998)
- De Marzo AM, "Proliferative inflammatory atrophy of the prostate : implications for prostatic carcinogenesis", Am J Pathol, 155, pp.1985~1992 (1999)
- Vaupel P, "The role of hypoxia-induced factors in tumor progression", Oncologist, 5, pp.10~17 (2004)
- Zhang H, "HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells", Biochem Biophys Res Commun, 476, pp.146~152 (2016)
- Towler MC, "AMP-activated protein kinase in metabolic control and insulin signaling", Circ Res, 100, pp.328~341 (2007)
- Wang W, "AMP-activated protein kinase and cancer", Acta Physiol(Oxf), 196, pp.55~63 (2009)
- Hallows KR, "Role of the energy sensor AMP-activated protein kinase in renal physiology and disease", Am J Physiol Renal Physiol, 298, pp.F1067~F1077 (2010)
- Fukuyama Y, "Hypoxia induces expression and activation of AMPK in rat dental pulp cells", J Dent Res, 86, pp.903~907 (2007)
- Emerling BM, "Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP", ATP ratio, 2009, pp.46, 1386~1391
- Jeong JH, "4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation", Biochem Biophys Res Commun, 406, pp.353~358 (2011)
- Hsu CC1, "Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells", Biochim Biophys Acta, 1830, pp.4743~4751 (2013)
- Wang Y, "Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1", Proc Natl Acad Sci U S A, 109, pp.4892~4897 (2012)
- Jiang R, "Hypoxic trophoblast HMGB1 induces endothelial cell hyperpermeability via the TRL-4", caveolin-1 pathway, 2014, pp.193, 5000~5012
- Mao X, "Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma", Cancer Res, 76, pp.7242~7253 (2016)
- Cohen AW, "Role of caveolae and caveolins in health and disease", Physiol Rev, 84, pp.1341~1379 (2004)
- Williams TM, "Caveolin-1 in oncogenic transformation, cancer, and metastasis", Am J Physiol Cell Physiol, 288, pp.C494~506 (2005)
- Liu J, "Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation", Am J Physiol Cell Physiol, 280, pp.C823~35 (2001)
- Sanchez-Carbayo M, "Molecular profiling of bladder cancer using cDNA microarrays : defining histogenesis and biological phenotypes", Cancer Res, 62, pp.6973~6980 (2002)
- Mungai PT, "Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels", Mol Cell Biol, 31, pp.3531~3545 (2011)
- Treins C, "AMPK activation inhibits the expression of HIF-1alpha induced by insulin and IGF-1", Biochem Biophys Res Commun, 342, pp.1197~1202 (2006)
- Park SJ, "AMPK activation reduces vascular permeability and airway inflammation by regulating HIF", VEGFA pathway in a murine model of toluene diisocyanate-induced asthma, 2012, pp.61, 1069~1083
- Zhou X, "Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma", Oncotarget, 7, pp.873~884 (2016)
- Polyák E, "Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy", J Urol, 182, pp.2497~2503 (2009)
- Boopathi E, "Transcriptional repression of Caveolin-1(CAV1)gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings", Am J Pathol, 178, pp.2236~2251 (2011)
- Sullivan MP, "Regional distribution and molecular interaction of caveolins in bladder smooth muscle", BJU Int, 110, pp.E1163~72 (2012)
- Xie L, "Hypoxia-inducible factor", MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of hosphor, leading to hypoxia-induced inflammation, 2014, pp.34, 3013~3023
- Kannan A, "Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition", Eur J Cancer, 50, pp.204~215 (2014)
- Martinez-Outschoorn UE, "Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment", Cell Cycle, 9, pp.3515~3533 (2010)
- Sotgia F, "Caveolin-1 and cancer metabolism in the tumor microenvironment:markers, models, and mechanisms", Annu Rev Pathol, 7, pp.423~467 (2012)
- Lisanti MP, "Oncogenes induce the cancer-associated fibroblast phenotype : metabolic symbiosis and"fibroblast addiction"are new therapeutic targets for drug discovery", Cell Cycle, 12, pp.2723~2732 (2013)
- Salani B, "Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells", FASEB J, 26, pp.788~798 (2012)